Compounds > trapidil
Page last updated: 2024-11-05

trapidil and Placenta Diseases

trapidil has been researched along with Placenta Diseases in 3 studies

Trapidil: A coronary vasodilator agent.

Placenta Diseases: Pathological processes or abnormal functions of the PLACENTA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dodd, JM2
McLeod, A2
Windrim, RC2
Kingdom, J2
Köpernick, H1
Mest, HJ1
Schwarz, B1

Reviews

2 reviews available for trapidil and Placenta Diseases

ArticleYear
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    The Cochrane database of systematic reviews, 2013, Jul-24, Issue:7

    Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low

2013
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    The Cochrane database of systematic reviews, 2010, Jun-16, Issue:6

    Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei

2010

Other Studies

1 other study available for trapidil and Placenta Diseases

ArticleYear
Pharmacological management of an impending placental insufficiency.
    Prostaglandins, leukotrienes, and essential fatty acids, 1988, Volume: 33, Issue:3

    Topics: Aspirin; Epoprostenol; Female; Gestational Age; Humans; Microcirculation; Placenta Diseases; Placent

1988